Vitamin D acts on a series of regulatory and signaling processes in the liver parenchyma, which are closely related to energy metabolism and inflammatory responses. This immune-inflammatory role is particularly interesting for understanding the correlation between serum vitamin D levels, obesity, and nonalcoholic fatty liver disease (NAFLD).
Methods:
This retrospective observational study collected secondary data from medical records of patients who underwent bariatric surgery with vertical gastrectomy from 2014 to 2018. After applying the inclusion and exclusion criteria, 164 patients were selected, with preoperative analysis of anthropometric, clinical, biochemical, and imaging parameters.
Results:
The group without steatosis showed higher serum vitamin D levels (in median) when compared to the groups with mild and moderate/severe steatosis, respectively. When vitamin D status and variables related to social drinking, body mass index degree, and lipid profile were evaluated, only alcohol consumption was associated with vitamin D insufficiency (p = 0.042).
Conclusions:
There is a high prevalence of vitamin D insufficiency/deficiency in the bariatric surgery preoperative period. Furthermore, it was not possible to establish a causal relationship between vitamin D deficiency and NAFLD, notwithstanding the verification of higher serum vitamin D levels in individuals who did not have liver lesions on ultrasonography.
Get full access to this article
View all access options for this article.
References
1.
CharoenngamN, HolickMF. Immunologic effects of vitamin D on human health and disease. Nutrients [Internet] 2020 15;12(7):2097; doi: 10.3390/nu12072097
2.
VranićL, MikolaševićI, MilićS. Vitamin D deficiency: Consequence or cause of obesity?. Medicina [Internet], 2019; 55(9):541; doi: 10.3390/medicina55090541
3.
MigliaccioS, Di NisioA, MeleC, et al.Obesity and hypovitaminosis D: Causality or casualty?. Int J Obes Suppl, 2019; 9(1):20–31; doi: 10.1038/s41367-019-0010-8
4.
MaM, LongQ, ChenF, et al.Active vitamin D impedes the progression of non-alcoholic fatty liver disease by inhibiting cell senescence in a rat model. Clin Res Hepatol Gastroenterol, 2020; 44(4):513–523; doi: 10.1016/j.clinre.2019.10.007
5.
TargherG, BertoliniL, ScalaL, et al.Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis, 2007; 17(7):517–524; doi: 10.1016/j.numecd.2006.04.002
6.
LeungPS. The modulatory action of vitamin D on the renin–angiotensin system and the determination of hepatic insulin resistance. Molecules [Internet], 2019; 24(13):2479; doi: 10.3390/molecules24132479
7.
BarchettaI, CiminiF, CavalloM. Vitamin D supplementation and non-alcoholic fatty liver disease: Present and future. Nutrients, 2017; 9(9):1015; doi: 10.3390/nu9091015
8.
HolickMF, BinkleyNC, Bischoff-FerrariHA, et al.Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2011; 96(7):1911–1930; doi: 10.1210/jc.2011-0385
9.
LimaLM, Carvalho M dasG, SoaresAL, et al.High-sensitivity C-reactive protein in subjects with type 2 diabetes mellitus and/or high blood pressure. Arq Bras Endocrinol Metabol, 2007; 51(6):956–960; doi: 10.1590/S0004-27302007000600010
10.
SaverymuttuSH, JosephAE, MaxwellJD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed), 1986; 292(6512):13–15; doi: 10.1136/bmj.292.6512.13
11.
ChakhtouraMT, NakhoulNN, ShawwaK, et al.Hypovitaminosis D in bariatric surgery: A systematic review of observational studies. Metabolism, 2016; 65(4):574–585; doi: 10.1016/j.metabol.2015.12.004
12.
ParrottJ, FrankL, RabenaR, et al.American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients. Surg Obes Relat Dis, 2017; 13(5):727–741; doi: 10.1016/j.soard.2016.12.018
13.
MaedaSS, BorbaVZC, CamargoMBR, et al.Recomendações da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) para o diagnóstico e tratamento da hipovitaminose D. Arq Bras Endocrinol Metabol, 2014; 58(5):411–433; doi: 10.1590/0004-2730000003388
14.
VivanMA, KopsNL, FülberER, et al.Prevalence of vitamin D depletion, and associated factors, among patients undergoing bariatric surgery in Southern Brazil. Obes Surg, 2019 25;29(10):3179–3187; doi: 10.1007/s11695-019-03963-9
15.
dos SantosEM, de LimaDSC, PadilhaBM, et al.Vitamin D in the preoperative and postoperative periods of bariatric surgery. Obes Surg, 2021; 31(6):2723–2728; doi: 10.1007/s11695-021-05329-6
16.
Mônaco-FerreiraDV, Leandro-MerhiVA, AranhaNC, et al.Vitamin D deficiency and paratohommonium increase in late postoperative gastric bypass in Roux-en-Y. Arq Bras Cir Dig, 2018; 31(4):e1407; doi: 10.1590/0102-672020180001e1407
17.
CambiMP, MarchesiniSD, BarettaGA. Post-bariatric surgery weight regain: evaluation of nutritional profile of candidate patients for endoscopic argon plasma coagulation. Arq Bras Cir Dig, 2015; 28(1):40–43; doi: 10.1590/S0102-67202015000100011
18.
SavastanoS, BarreaL, SavanelliMC, et al.Low vitamin D status and obesity: Role of nutritionist. Rev Endocr Metab Disord, 2017; 18(2):215–225; doi: 10.1007/s11154-017-9410-7
19.
ChanL-N, NeilsonCH, KirkEA, et al.Optimization of vitamin D status after Roux-en-Y gastric bypass surgery in obese patients living in Northern Climate. Obes Surg, 2015; 25(12):2321–2327; doi: 10.1007/s11695-015-1685-8
20.
AzevedoM, BandeiraL, LuzaC, et al.Vitamin D deficiency, skin phototype, sun index, and metabolic risk among patients with high rates of sun exposure living in the tropics. J Clin Aesthet Dermatol, 2018; 11(8):15–18.
21.
SukikA, AlalwaniJ, GanjiV. Vitamin D, gut microbiota, and cardiometabolic diseases-a possible three-way axis. Int J Mol Sci, 2023; 24(2):940; doi: 10.3390/ijms24020940
22.
WijniaJW, WieldersJPM, LipsP, et al.Is Vitamin D Deficiency a Confounder in Alcoholic Skeletal Muscle Myopathy?. Alcohol Clin Exp Res, 2012; 37:E209–E215; doi: 10.1111/j.1530-0277.2012.01902.x
CazzoE, de Felice GalloF, ParejaJC, et al.Nonalcoholic fatty liver disease in morbidly obese subjects: Correlation among histopathologic findings, biochemical features, and ultrasound evaluation. Obes Surg, 2014; 24(4):666–668; doi: 10.1007/s11695-014-1183-4
25.
FinelliC, PadulaMC, MartelliG, et al.Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?. World J Gastroenterol, 2014; 20(44):16649; doi: 10.3748/wjg.v20.i44.16649
26.
DasarathyJ, PeriyalwarP, AllampatiS, et al.Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int, 2013; 34(6):e118–e127; doi: 10.1111/liv.12312
27.
WangX, LiW, ZhangY, et al.Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Results from a meta-analysis. Int J Clin Exp Med, 2015; 8(10):17221–17234.
28.
NelsonJE, RothCL, WilsonLA, et al.Vitamin D deficiency is associated with increased risk of non-alcoholic steatohepatitis in adults with non-alcoholic fatty liver disease: Possible role for MAPK and NF-κB?. Am J Gastroenterol, 2016; 111(6):852–863; doi: 10.1038/ajg.2016.51
29.
AbramovitchS, SharvitE, WeismanY, et al.Vitamin D inhibits development of liver fibrosis in an animal model but cannot ameliorate established cirrhosis. Am J Physiol Gastrointest Liver Physiol, 2015; 308(2):G112–G120; doi: 10.1152/ajpgi.00132.2013
30.
SharifiN, AmaniR, HajianiE, et al.Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine, 2014; 47(1):70–80; doi: 10.1007/s12020-014-0336-5
31.
VeugelersP, PhamT-M, EkwaruJ. Optimal vitamin D supplementation doses that minimize the risk for both low and high serum 25-hydroxyvitamin D concentrations in the general population. Nutrients, 2015; 7(12):10189–10208; doi: 10.3390/nu7125527
